Skip to main content
Fig. 2 | Journal of Orthopaedic Surgery and Research

Fig. 2

From: LncRNA EBLN3P attributes methotrexate resistance in osteosarcoma cells through miR-200a-3p/O-GlcNAc transferase pathway

Fig. 2

Knockdown EBLN3P increases MTX sensitivity of osteosarcoma cells. A qRT-PCR comparison of EBLN3P expression after knocking down EBLN3P (EBLN3P-si). **p < 0.01. B and C The migration ability of MNNG/HOS-MTXr and MG63-MTXr cells decreased significantly after knockdown of EBLN3P. **p < 0.01. D and E Comparison of cell viability of the 2 MTX-resistant cell line after knocking down of EBLN3P. * p < 0.05, **p < 0.01, compared with EBLN3P NC at the same dose

Back to article page

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X